Optimisation of mesenchymal stromal cells karyotyping analysis: Implications for clinical use

Transfusion Medicine

Volumn 22, Issue 2, 2012, Pages 122-127

  Muntion S ^a,b,c   Sanchez Guijo F M ^a,b,c   Carrancio, S ^a,b,c   Villaron E ^a,b,c   Lopez O ^a,b,c   Diez Campelo, M ^a,b,c   San Miguel, J F ^a,b,c   del Canizo M C ^a,b,c  

^a ISCIII)   (Spain)

^b HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^c CSIC   (Spain)

Author keywords

Citogenetics; Karyotyping; Mesenchymal stem cells; Therapy cellular

Indexed keywords

DEMECOLCINE;

ADULT; AGED; ARTICLE; CHROMOSOME 10; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; FEMALE; GOOD MANUFACTURING PRACTICE; HUMAN; HUMAN CELL; IN VITRO STUDY; KARYOTYPING; MALE; MESENCHYMAL STROMA CELL; METAPHASE; TRISOMY;

CELLS, CULTURED; FEMALE; HUMANS; KARYOTYPING; MALE; MESENCHYMAL STROMAL CELLS; METAPHASE;

EID: 84858793282     PISSN: 09587578     EISSN: 13653148     Source Type: Journal    
DOI: 10.1111/j.1365-3148.2012.01134.x     Document Type: Article

References (25)

1. Bernardo, M.E., Zaffaroni, N., Novara, F. et al. (2007) Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Research, 67, 9142-9149.
2. Carrancio, S., Lopez-Holgado, N., Sanchez-Guijo, F.M. et al. (2008) Optimization of mesenchymal stem cell expansion procedures by cell separation and culture conditions modification. Experimental Hematology, 36, 1014-1021.
3. Dominici, M., Le, B.K., Mueller, I. et al. (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 8, 315-317.
4. (1997) Tissue Culture and Molecular Cell Technologies, 164-178. Beijing Publishing House, Beijing.
5. Fuente, R., Bernad, A., Garcia-Castro, J., Martin, M.C. & Cigudosa, J.C. (2010) Retraction: spontaneous human adult stem cell transformation. Cancer Research, 70, 6682.
6. Garcia, J.L., Hernandez, J.M., Gutierrez, N.C., Fernandez, P. & Rios, A. (1996) Cytogenetics in the study of malignant blood diseases. Sangre, 41, 289-295.
7. Garcia, S., Bernad, A., Martin, M.C., Cigudosa, J.C., Garcia-Castro, J. & de la, F.R. (2010) Pitfalls in spontaneous in vitro transformation of human mesenchymal stem cells. Experimental Cell Research, 316, 1648-1650 [Epub 18 February 2010].
8. Gosden, J.R. (1994) Immortalized cell lines: chromosome preparation and banding. In: Methods in Molecular Biology: Chromosome Analysis Protocols (ed Fletcher, J.), 29, 53-56. Humana Press Inc., Totowa, New Jersey.
9. Han, C., Zhang, X., Xu, W., Wang, W., Qian, H. & Chen, Y. (2005) Cloning of the nucleostemin gene and its function in transforming human embryonic bone marrow mesenchymal stem cells into F6 tumor cells. International Journal of Molecular medicine, 16, 205-213.
10. Hernandez, J.M., Tabernero, M.D. & Garcia, J.L. (1996) Applications of fluorescence in situ hybridization in the study of hematologic neoplasms. Sangre, 41, 305-309.
11. Mareschi, K., Ferrero, I., Rustichelli, D., Aschero, S., Gammaitoni, L., Aglietta, M., Madon, E. & Fagioli, F. (2006) Expansion of mesenchymal stem cells isolated from pediatric and adult donor bone marrow. Journal of Cellular Biochemistry, 97, 744-754.
12. Marquez, C., Egozcue, J., Martorell, M.R., Moreno, V. & Templado, C. (1996) Colcemid increases the frequency of chromosome abnormalities in human sperm. Cytogenetics and Cell Genetics, 72, 164-170.
13. Minguell, J.J., Erices, A. & Conget, P. (2001) Mesenchymal stem cells. Experimental biology and medicine (Maywood, N.J.), 226, 507-520.
14. Ozawa, K., Sato, K., Oh, I. et al. (2008) Cell and gene therapy using mesenchymal stem cells (MSCs). Journal of Autoimmunity, 30, 121-127.
15. Perez-Ilzarbe, M., Diez-Campelo, M., Aranda, P. et al. (2009) Comparison of ex vivo expansion culture conditions of mesenchymal stem cells for human cell therapy. Transfusion, 49, 1901-1910.
16. Perez Simon, J.A., Lopez-Villar, O., Andreu, E.J. et al. (2011) Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I/II clinical trial. Haematologica, 96, 1072-1076.
17. Rubio, D., Garcia-Castro, J., Martin, M.C., de la, F.R., Cigudosa, J.C., Lloyd, A.C. & Bernad, A. (2005) Spontaneous human adult stem cell transformation. Cancer Research, 65, 3035-3039.
18. Rubio, D., Garcia, S., Paz, M.F., De la, C.T., Lopez-Fernandez, L.A., Lloyd, A.C., Garcia-Castro, J. & Bernad, A. (2008) Molecular characterization of spontaneous mesenchymal stem cell transformation. PLoS One, 3, e1398.
19. Sanchez-Guijo, F.M., Blanco, J.F., Cruz, G. et al. (2009) Multiparametric comparison of mesenchymal stromal cells obtained from trabecular bone by using a novel isolation method with those obtained by iliac crest aspiration from the same subjects. Cell and Tissue Research, 336, 501-507.
20. Sensebe, L., Bourin, P. & Tarte, K. (2011) Good manufacturing practices production of mesenchymal stem/stromal cells. Human Gene Therapy, 22, 19-26.
21. Tarte, K., Gaillard, J., Lataillade, J.J. et al. (2010) Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation. Blood, 115, 1549-1553 [Epub 23 December 2010].
22. Villaron, E.M., Almeida, J., Lopez-Holgado, N. et al. (2004) Mesenchymal stem cells are present in peripheral blood and can engraft after allogeneic hematopoietic stem cell transplantation. Haematologica, 89, 1421-1427.
23. Wang, Y., Huso, D.L., Harrington, J., Kellner, J., Jeong, D.K., Turney, J. & McNiece, I.K. (2005) Outgrowth of a transformed cell population derived from normal human BM mesenchymal stem cell culture. Cytotherapy, 7, 509-519.
24. Wolff, D., Schleuning, M., von, H.S. et al. (2011) Consensus conference on clinical practice in chronic gvhd: second-line treatment of chronic graft-versus-host disease. Biology of Blood and Marrow Transplantation, 17, 1-17 [Epub 26 May 2010].
25. Zhang, Z.X., Guan, L.X., Zhang, K., Wang, S., Cao, P.C., Wang, Y.H., Wang, Z. & Dai, L.J. (2007) Cytogenetic analysis of human bone marrow-derived mesenchymal stem cells passaged in vitro. Cell Biology International, 31, 645-648.